Latest Breaking News On - Innocare pharma limited stock exchange - Page 1 : comparemela.com

Core business grew steadily and profitability continued to improve Results Highlights Revenue amounted to approximately RMB10,265.2 million, representing a significant increase of 25.6%, among which. | March 28, 2023

Mixue bingchengChayan yueseSf holding groupGroup city logistics systemGroup deliver for meDouyin life servicesHangzhou sf industrial co ltdStock codeReporting periodShopping festivalsCity logistics systemInnocare pharma limited stock exchangePress releaseMong 9969 kyg4783b1032